Newstral
Article
Mmarketwatch.com on 2019-05-08 14:40
Gilead strikes deal with biotech Goldfinch Bio to tackle kidney diseases
Related news
- MBiotech company Forty Seven surges 30% after hours on Gilead interest: reportmarketwatch.com
- DGoldfinchdowneast.com
- BGilead Way Oversold As Investors Flee Biotechbarrons.com
- Gilead: the Apple of the Biotech Worldwsj.com
- AbbVie vs. Gilead: Biotech faces price warsThe Salt Lake Tribune
- Kidney Diseases Not Death Sentence – UPTHindependent.ng
- Dehydration, anaemia may hasten kidney diseases – Grouppunchng.com
- Senate wants NHIS coverage for kidney diseasespunchng.com
- D‘Tackle Obesity To Reduce Kidney Diseases’dailyguideafrica.com
- NRevolutionary biotech to combat deadly diseasesnouse.co.uk
- LGene Therapy Market Size, Forecast to 2028 | Key Manufacturers – Novartis AG, Biogen, Gilead Sciences MolMed S.p.A., Spark Therapeutics Orchard Therapeutics plc., SIBIONO, Bluebird bio Shanghai Sunway Biotech Co. Ltd.liverpoolstudentmedia.com
- BBuy Big Biotech — But Not Gilead, Analyst Saysbarrons.com
- Gilead Sciences acquires German biotech company for $1.39 billionbizjournals.com
- Stocks This Week: Buy The Biotech Stocks: Amgen And GileadForbes
- FGilead to raise stake in Belgian biotech in $5.1bn dealft.com
- Gilead buying Danish biotech, but deal days far from overbizjournals.com
- GAlcoholic Hepatiti Drug Market Analysis, Size, Growth and Key Players : Alfact Innovation, Generon (Shanghai) Corp Ltd, Gilead Sciences Inc, GRI Bio Inc, Immuron Ltd, Intercept Pharmaceuticals Inc, Promethera Biosciences SA, Verlyx Pharma Inc, Vital Therapies Incgalleonnews.com
- TStudy reveals prevalent of acute kidney diseases among childrenthepoint.gm
- Expert advocates prevention, screening, timely treatment of kidney diseasestribuneonlineng.com
- Researchers to investigate kidney diseases in Kano, Yobepunchng.com